424 filings
Page 3 of 22
424B5
lym8w qrwa7pd4k839t
21 Nov 22
Prospectus supplement for primary offering
8:00am
8-K
v8jql3iv4 hb6o4e2pty
7 Nov 22
Cassava Sciences Reports Third Quarter Financial Results for 2022 and Business Updates
9:09am
8-K
jd3bzyge
3 Nov 22
Regulation FD Disclosure
9:26am
8-K
9koli03n6
27 Oct 22
Cassava Sciences Announces Expansion of Leadership Team
4:03pm
8-K
yyepaq1q
23 Sep 22
Regulation FD Disclosure
9:05am
8-K
m0tu3zilqxprgbcxv9l
3 Aug 22
Cassava Sciences Reports Second Quarter Financial Results for 2022, Mid-year Corporate Update and Interim Analysis of Open-label Study
9:25am
424B5
m2nhs0z
29 Jul 22
Prospectus supplement for primary offering
4:15pm
S-8
bzljf8kb4jqps0
10 Jun 22
Registration of securities for employees
5:22pm
8-K
bqijwtxfsoxx931i
9 May 22
Submission of Matters to a Vote of Security Holders
4:52pm
8-K
0elxe 0k0ct
5 May 22
Cassava Sciences Reports First Quarter Financial Results for 2022 and Updates on Phase 3 Clinical Program
9:04am
8-K
sq45zqy k8
26 Apr 22
Regulation FD Disclosure
3:45pm
8-K
na5896
28 Feb 22
Cassava Sciences Reports Full-year 2021 Financial Results and Operating Updates
12:00am
8-K
7wcwc
6 Jan 22
Departure of Directors or Certain Officers
4:46pm
8-K
2g347 q0fw5v0k5
10 Nov 21
Cassava Sciences Reports Third Quarter 2021 Financial Results
9:10am